NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$4.66 and traded as high as C$5.14. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.05, with a volume of 209,259 shares changing hands.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on NWH.UN shares. BMO Capital Markets lowered their price target on NorthWest Health Prop Real Est Inv Trust from C$6.00 to C$5.00 in a research report on Friday, February 9th. Cormark upgraded NorthWest Health Prop Real Est Inv Trust from a “market perform” rating to a “buy” rating in a research note on Thursday, March 21st. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, NorthWest Health Prop Real Est Inv Trust presently has a consensus rating of “Hold” and a consensus price target of C$6.29.
Check Out Our Latest Research Report on NWH.UN
NorthWest Health Prop Real Est Inv Trust Stock Performance
NorthWest Health Prop Real Est Inv Trust Company Profile
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Read More
- Five stocks we like better than NorthWest Health Prop Real Est Inv Trust
- The Most Important Warren Buffett Stock for Investors: His Own
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is a Death Cross in Stocks?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Conference Calls and Individual Investors
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.